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More studies are needed to determine which exercise
programmes for intermittent claudication should be
funded.
We read with interest the editorial by Popplewell and
Bradbury.1 Treatment of claudicants aims at improving
health related quality of life (HRQoL) by improved daily-life
walking. Treadmill walking distance but not HRQoL improves
more with, for example, hospital based supervised exercise
programmes (SEP) than with unsupervised exercise pro-
grammes (UEP). Treadmill walking, the primary outcome in
many studies, is also used as training modality in many SEPs
but not in UEPs or home based (HEP) supervised exercise
programmes, introducing a risk of bias. Moreover, the
outcome treadmill walking is questioned and daily-life
walking (GPS monitored) or corridor tests (e.g. 6 minute
walk test, 6MWT) correlate better to HRQoL.2 Many clau-
dicants dislike prolonged training programmes and compli-
ance to SEP may be only 20e40% at 1 year.3 We identiﬁed
seven randomized and two non-randomized controlled tri-
als in a recently submitted systematic review (unpublished)
evaluating HEP compared with SEP or UEP. HEP and UEP
were inferior to SEP regarding treadmill walking whereas
HEP improved the 6MWT compared with UEP and SEP.
Hence, although SEP improves treadmill walking, the
generalizability to claudicants in general may be uncertain
and the links to improved daily-life walking and HRQoL
unclear. We agree that further RCTs are required and sug-
gest these should include 12 month follow up, HRQoL,
and “daily-life” walk tests. We have started such a study
comparing SEP, HEP, and UEP (SUNFIT Trial, ClinicalTrials.gov
NCT02341716) and hopefully further studies will be initi-
ated. We believe they are needed.
REFERENCES
1 Popplewell MA, Bradbury AW. Why do health systems not fund
supervised exercise programmes for intermittent claudication?
Eur J Vasc Endovasc Surg 2014;48(6):608e10.
2 Nordanstig J, Broeren M, Hensäter M, Perlander A, Osterberg K,
Jivegård L. Six-minute walk test closely correlates to “real-life”
outdoor walking capacity and quality of life in patients with
intermittent claudication. J Vasc Surg 2014;60(2):404e9.
3 Layden J, Michaels J, Bermingham S, Higgins B. Guideline
Development Group. Diagnosis and management of lower limb
peripheral arterial disease: summary of NICE guidance. BMJ
2012;345:e4947.
L. Jivegård*, J. Nordanstig
Department of Vascular Surgery, Sahlgrenska University
Hospital, Göteborg, Sweden*Corresponding author. Department of Vascular Surgery,
Sahlgrenska University Hospital, Göteborg, Sweden.
Email-address: lennart.jivegard@vgregion.se (L. Jivegård)
 2015 European Society for Vascular Surgery. Published by
Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejvs.2015.03.057
DOI of original article: http://dx.doi.org/10.1016/
j.ejvs.2015.04.019Re: ‘More Studies are Needed to Determine Which
Exercise Programmes for Intermittent Claudication Should
be Funded’
We would like to thank the authors of the SUNFIT trial for
their input on this important issue in response to our recent
editorial on this subject.1 We agree that good quality evi-
dence surrounding patient-centred outcomes such as
health-related quality of life is missing in the current liter-
ature, with too many studies focusing on multiple “perfor-
mance”-related outcomes such as maximal walking distance
and treadmill walking.
Hopefully the upcoming SUNFIT trial will shed some light
on which intervention, if any, provides a more long-term,
clinical, and cost-effective therapy for our patients with
intermittent claudication, vital evidence that the National
Institute for Health Care and Excellence called for in the
published Clinical Guideline 147.2 We would also advocate
the need for such a study in the UK to help advise patients,
clinicians, and healthcare providers.
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